TP53 and neoplasm: Indeed, wild-type p53 has been shown to suppress constitutive NFκB activity and lead to apoptosis (Shao et al, 2000), suggesting that tumours expressing wild-type p53 may be more susceptible to aspirin-induced apoptosis.